Form 4: Liquidia Corp Chief Accounting Officer Receives Significant RSU Grant, Boosting Beneficial Ownership

Liquidia Corp's Chief Accounting Officer, Dana Boyle, was granted 25,000 restricted stock units (RSUs), increasing her total beneficial ownership in the company to 188,361 shares.

Summary

• Dana Boyle, Chief Accounting Officer of Liquidia Corp (LQDA), acquired 25,000 shares of common stock in the form of Restricted Stock Units (RSUs) on July 1, 2025.
• Each RSU represents a contingent right to receive one share of Liquidia Corp's common stock.
• The transaction price for these RSUs was $0.
• Following this transaction, Dana Boyle's total beneficial ownership in Liquidia Corp stands at 188,361 shares.
• The newly granted 25,000 RSUs will vest 25% on July 11, 2026, with the remaining RSUs vesting ratably on a quarterly basis over three years thereafter.
• The total beneficial ownership of 188,361 shares includes 2,826 unvested RSUs from a January 16, 2022 grant, 21,875 unvested RSUs from a January 25, 2023 grant, 39,245 unvested RSUs from a January 11, 2024 grant, 50,861 RSUs from a January 11, 2025 grant (none vested as of July 1, 2025), and 11,029 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.

Sentiment

Score: 6

Explanation: The document reports a routine executive compensation event (RSU grant) which is generally positive for aligning management interests with shareholders, but does not contain information that would significantly alter the company's financial outlook or operations.

Positives

• The grant of Restricted Stock Units to a key executive like the Chief Accounting Officer aligns management's interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.
• Increased insider ownership can signal confidence in the company's future prospects.

Future Outlook

The vesting schedule for the newly granted RSUs indicates future share issuance over the next three years, contingent on continued employment and company performance, which will contribute to the executive's long-term compensation.

Industry Context

The grant of Restricted Stock Units (RSUs) is a common form of executive compensation in the biotechnology and pharmaceutical industries, used to attract, retain, and incentivize key talent by aligning their financial interests with the long-term performance of the company.

Comparison to Industry Standards

• RSU grants are a standard component of executive compensation packages across various industries, including biotech and pharma, serving as a long-term incentive.
• The vesting schedule, with an initial cliff followed by quarterly vesting over three years, is a common structure designed to encourage executive retention and sustained performance.

Stakeholder Impact

• Shareholders: The RSU grant represents potential future dilution as shares vest, but also signifies management's increased stake and alignment with shareholder interests.
• Employees: This specific filing pertains to a senior executive's compensation and does not directly impact the broader employee base, though it reflects the company's compensation strategy for key personnel.

Next Steps

• Vesting of the 25,000 RSUs will commence on July 11, 2026, with subsequent quarterly vesting over the following three years.

Key Dates

Keywords

Liquidia Corp, LQDA, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Grant, Executive Compensation, Beneficial Ownership, Chief Accounting Officer, Stock Vesting